US Blocks Sale of a Company's Mail-Order Gene Tests

U.S. health regulators have ordered a genetic-testing company to stop marketing its mail-order test kits, saying consumers might get false results that cause them to undergo unnecessary medical procedures. A start-up company called 23andMe has been selling its $99 kits for five years. It had started a new marketing campaign before the government's Food and Drug Administration halted its sales until the firm proves that its tests are accurate. The health regulators said they were...

© La Voix de l'Amérique - mardi 26 novembre 2013